Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00036283
Status:
COMPLETED
Last Update Posted:
2008-09-29
First Post:
2002-05-08
Brief Title:
Chemoprevention of Oral Premalignant Lesions
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Clinical Protocol For A Phase II Double-Blind Placebo-Controlled Randomized Study Of Celecoxib Sc-58635 In Oral Premalignant Lesions Investigator IND
Status:
COMPLETED
Status Verified Date:
2008-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Reduction in size and number of oral premalignant lesions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None